Our Focus on Immuno-Oncology
In the field of immuno-oncology, the STAM™ mouse is the most pathologically suitable model for developing new therapeutic drugs for liver cancer.
The utilization of STAM™ mouse enables non-clinical research for the development of liver cancer therapeutics targeting immune cells, tumor microenvironment, and genetic mutations.
NEWS RELEASE
2025 Highlights — Research and Business Topics at SMC Laboratories —
We sincerely thank you for your continued support and collaboration with SMC Laboratories throughout 2025. Thi…
EVENT
SMC Laboratories at BIO Partnering™ @JPM Week 2026
SMC Laboratories will participate in BIO Partnering™ @JPM Week 2026, held in January 2026 during JPM Healthcar…
Stem Cell Res Ther.
MicroRNA-4516 in extracellular vesicles-derived mesenchymal stem cells suppressed integrin αV-mediated lung fibrosis ( doi: 10.1186/s13287-025-04559-0.)
CDAHFD Model
The CDAHFD model is a widely used and well-characterized model for the evaluation of pharmacological efficacy of new treatments against liver inflammation, liver fibrosis and fatty liver diseases such as MASLD (formerly: NAFLD).
